Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma

标题
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
作者
关键词
-
出版物
MELANOMA RESEARCH
Volume -, Issue -, Pages 1
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2018-09-27
DOI
10.1097/cmr.0000000000000509

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now